CN103800601A - Traditional Chinese medicine composition for treating hepatitis - Google Patents

Traditional Chinese medicine composition for treating hepatitis Download PDF

Info

Publication number
CN103800601A
CN103800601A CN201410046564.9A CN201410046564A CN103800601A CN 103800601 A CN103800601 A CN 103800601A CN 201410046564 A CN201410046564 A CN 201410046564A CN 103800601 A CN103800601 A CN 103800601A
Authority
CN
China
Prior art keywords
grams
gram
chinese medicine
medicine composition
herba
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410046564.9A
Other languages
Chinese (zh)
Inventor
刘璐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410046564.9A priority Critical patent/CN103800601A/en
Publication of CN103800601A publication Critical patent/CN103800601A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating hepatitis, which is prepared from 6-15g of radix codonopsitis, 7-16g of Bighead Atractylodes Rhizome, 10-20g of rhizoma atractylodis, 4-13g of wrinkled gianthyssop, 6-15g of oriental wormwood, 7-18g of angelica, 10-20g of white peony root, 7-15g of rhizoma cyperi, 10-23g of fingered citron, 4-12g of boneset and 4-9g of cowherb seed. The traditional Chinese medicine composition has the advantages of simple preparation process, favorable absorption effect, obvious curative effect, no side effect and high safety, and is beneficial to relieving symptoms for patients in time.

Description

The Chinese medicine composition for the treatment of hepatitis
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of hepatitis.
Background technology
Hepatitis, typically refers to by multiple paathogenic factor-as virus, parasite, medicine and poisonous substance etc., infringement liver, is damaged the cell of liver, and the function of liver suffers damage, and it can cause a series of malaise symptoms of health, and liver function index is abnormal.Viral hepatitis is the infectious disease being caused by multiple different hepatitis viruss, and according to etiological diagnosis, hepatitis virus has five kinds at least, i.e. first, second, third, fourth, hepatitis E virus, causes respectively first, second, third, fourth, hepatitis E.Viral hepatitis is mainly by blood, body fluid communication.Occur jaundice take tired, loss of appetite, hepatomegaly, abnormal liver function as main manifestations, some cases clinically, symptomless infection is common.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of hepatitis.
In order to realize foregoing invention object, feature of the present invention is to be made by weight ratio by following crude drug: Radix Codonopsis 6-15 gram, Rhizoma Atractylodis Macrocephalae 7-16 gram, Rhizoma Atractylodis 10-20 gram, Herba Pogostemonis 4-13 gram, Herba Artemisiae Scopariae 6-15 gram, Radix Angelicae Sinensis 7-18 gram, Radix Paeoniae Alba 10-20 gram, Rhizoma Cyperi 7-15 gram, Fructus Citri Sarcodactylis 10-23 gram, Herba Lycopi 4-12 gram, Semen Vaccariae 4-9 gram.
The Chinese medicine composition optimum ratio for the treatment of hepatitis is: 10 grams of Radix Codonopsis, 12 grams of the Rhizoma Atractylodis Macrocephalaes, 15 grams of Rhizoma Atractylodis, 8 grams of Herba Pogostemoniss, 9 grams of Herba Artemisiae Scopariaes, 12 grams of Radix Angelicae Sinensis, 13 grams of the Radix Paeoniae Albas, 10 grams of Rhizoma Cyperis, 14 grams of Fructus Citri Sarcodactylis, 8 grams of Herba Lycopi, 7 grams of Semen Vaccariae.
In prescription, the drug effect of each taste Chinese medicine is as described below.
Radix Codonopsis invigorating the spleen and replenishing QI, spleen invigorating lung benefiting.
Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis.
Rhizoma Atractylodis are drying damp and strengthening spleen, wind-damp dispelling.
Agastachel patchoule summer heat dispelling induces sweat, removing dampness to restore normal function of the stomach.
Herba Artemisiae Scopariae clearing away heat-damp and promoting diuresis, jaundice eliminating, hepatic cholagogic, antiinflammatory.
Chinese angelica blood supplementing, invigorates blood circulation, and moisturizes laxation.
The Radix Paeoniae Alba easing the affected liver of enriching blood, suppressing the hyperactive liver analgesic therapy, yin fluid astringing is received antiperspirant.
The Rhizoma Cyperi resolving depression of regulating the flow of vital energy, menstruction regulating and pain relieving, antiabortive.
Fructus Citri Sarcodactylis activating QI to eliminate phlegm, preventing or arresting vomiting relieving distension, soothing liver and strengthening spleen, stomach function regulating.
Herba Lycopi's blood circulation promoting and blood stasis dispelling, line water detumescence.
Semen Vaccariae promoting blood circulation to restore menstrual flow, reducing swelling and alleviating pain.
Using method of the present invention is: crude drug is soaked in water 30 minutes, decocts 60 minutes, decoct 2 times for every dose, gained medicinal liquid is mixed.1 dose of every day, point 2 decoction being taken warmly.It within 30th, is a course for the treatment of.
Therapeutic effect: in 300 routine patients, clinical cure 276 examples, account for 92%; Effective 18 examples, account for 6%; Effective 2 examples, account for 0.67%; Invalid 4 examples, account for 1.3%.
As can be seen here, the present invention has the following advantages: preparation is simple, and good absorbing effect is evident in efficacy, has no side effect, safe, is conducive to patient and alleviates in time condition of illness.
The specific embodiment
10 grams of embodiment 1 Radix Codonopsis, 12 grams of the Rhizoma Atractylodis Macrocephalaes, 15 grams of Rhizoma Atractylodis, 8 grams of Herba Pogostemoniss, 9 grams of Herba Artemisiae Scopariaes, 12 grams of Radix Angelicae Sinensis, 13 grams of the Radix Paeoniae Albas, 10 grams of Rhizoma Cyperis, 14 grams of Fructus Citri Sarcodactylis, 8 grams of Herba Lycopi, 7 grams of Semen Vaccariae.
6 grams of embodiment 2 Radix Codonopsis, 7 grams of the Rhizoma Atractylodis Macrocephalaes, 10 grams of Rhizoma Atractylodis, 4 grams of Herba Pogostemoniss, 6 grams of Herba Artemisiae Scopariaes, 7 grams of Radix Angelicae Sinensis, 10 grams of the Radix Paeoniae Albas, 7 grams of Rhizoma Cyperis, 10 grams of Fructus Citri Sarcodactylis, 4 grams of Herba Lycopi, 4 grams of Semen Vaccariae.
15 grams of embodiment 3 Radix Codonopsis, 16 grams of the Rhizoma Atractylodis Macrocephalaes, 20 grams of Rhizoma Atractylodis, 13 grams of Herba Pogostemoniss, 15 grams of Herba Artemisiae Scopariaes, 18 grams of Radix Angelicae Sinensis, 20 grams of the Radix Paeoniae Albas, 15 grams of Rhizoma Cyperis, 23 grams of Fructus Citri Sarcodactylis, 12 grams of Herba Lycopi, 9 grams of Semen Vaccariae.
12 grams of embodiment 4 Radix Codonopsis, 14 grams of the Rhizoma Atractylodis Macrocephalaes, 15 grams of Rhizoma Atractylodis, 9 grams of Herba Pogostemoniss, 12 grams of Herba Artemisiae Scopariaes, 14 grams of Radix Angelicae Sinensis, 17 grams of the Radix Paeoniae Albas, 12 grams of Rhizoma Cyperis, 18 grams of Fructus Citri Sarcodactylis, 8 grams of Herba Lycopi, 6 grams of Semen Vaccariae.

Claims (2)

1. treat the Chinese medicine composition of hepatitis for one kind, it is characterized in that being made by weight ratio by following crude drug: Radix Codonopsis 6-15 gram, Rhizoma Atractylodis Macrocephalae 7-16 gram, Rhizoma Atractylodis 10-20 gram, Herba Pogostemonis 4-13 gram, Herba Artemisiae Scopariae 6-15 gram, Radix Angelicae Sinensis 7-18 gram, Radix Paeoniae Alba 10-20 gram, Rhizoma Cyperi 7-15 gram, Fructus Citri Sarcodactylis 10-23 gram, Herba Lycopi 4-12 gram, Semen Vaccariae 4-9 gram.
2. the Chinese medicine composition for the treatment of hepatitis according to claim 1, it is characterized in that being made by weight ratio by following crude drug: 10 grams of Radix Codonopsis, 12 grams of the Rhizoma Atractylodis Macrocephalaes, 15 grams of Rhizoma Atractylodis, 8 grams of Herba Pogostemoniss, 9 grams of Herba Artemisiae Scopariaes, 12 grams of Radix Angelicae Sinensis, 13 grams of the Radix Paeoniae Albas, 10 grams of Rhizoma Cyperis, 14 grams of Fructus Citri Sarcodactylis, 8 grams of Herba Lycopi, 7 grams of Semen Vaccariae.
CN201410046564.9A 2014-01-24 2014-01-24 Traditional Chinese medicine composition for treating hepatitis Pending CN103800601A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410046564.9A CN103800601A (en) 2014-01-24 2014-01-24 Traditional Chinese medicine composition for treating hepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410046564.9A CN103800601A (en) 2014-01-24 2014-01-24 Traditional Chinese medicine composition for treating hepatitis

Publications (1)

Publication Number Publication Date
CN103800601A true CN103800601A (en) 2014-05-21

Family

ID=50698296

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410046564.9A Pending CN103800601A (en) 2014-01-24 2014-01-24 Traditional Chinese medicine composition for treating hepatitis

Country Status (1)

Country Link
CN (1) CN103800601A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104547397A (en) * 2014-12-27 2015-04-29 山东明仁福瑞达制药股份有限公司 Traditional Chinese medicine formulation for treating hepatitis
KR101759436B1 (en) * 2015-05-22 2017-07-19 성균관대학교산학협력단 Composition comprising Pogostemonis Herba extract for preventing or treating liver damage
CN108096332A (en) * 2017-11-30 2018-06-01 枣阳千里香食品有限公司 A kind of Chinese medicine for treating chronic hepatitis

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104547397A (en) * 2014-12-27 2015-04-29 山东明仁福瑞达制药股份有限公司 Traditional Chinese medicine formulation for treating hepatitis
KR101759436B1 (en) * 2015-05-22 2017-07-19 성균관대학교산학협력단 Composition comprising Pogostemonis Herba extract for preventing or treating liver damage
CN108096332A (en) * 2017-11-30 2018-06-01 枣阳千里香食品有限公司 A kind of Chinese medicine for treating chronic hepatitis

Similar Documents

Publication Publication Date Title
CN101695566A (en) Chinese medicament for treating cephalagra
CN103800827A (en) Traditional Chinese medicine for treating liver cancer
CN103800601A (en) Traditional Chinese medicine composition for treating hepatitis
CN103655989A (en) Traditional Chinese medicine for external use for treating rheumatic arthritis
CN103142920B (en) Traditional Chinese medicine composition for treating hepatitis B and preparation method thereof
CN103301328B (en) Trigeminal neuralgia treatment medicine
CN103623157A (en) Medicine for treating facial paralysis
CN103656042A (en) Medicine for treating herpes zoster
CN103800799A (en) Traditional Chinese medicine for treating stomach cancer
CN102240342A (en) Traditional Chinese medicine for treating viral hepatitis A
CN104689144A (en) Drug for treating rheumatoid arthritis
CN105617042A (en) Traditional Chinese medicine composition for treating headache
CN103800456A (en) Traditional Chinese medicine composition for treating liver cancer
CN104383064A (en) Formula of Chinese herbal medicine for treating cervicitis
CN103800830A (en) Traditional Chinese medicine composition for treating hepatitis
CN105311460A (en) Traditional Chinese medicine for treating vascular neuralgia headache
CN103285289B (en) Traditional Chinese medicine for treating arthralgia
CN104800599A (en) Traditional Chinese medicinal composition for treating deficiency of kidney-yin
CN106606551A (en) Drug for treatment of dysmenorrhea
CN105031180A (en) Traditional Chinese medicine preparation for treating fever and preparation method thereof
CN103800828A (en) Traditional Chinese medicine for treating hepatitis
CN103800619A (en) Traditional Chinese medicine for treating rhinocarcinoma
CN103800829A (en) Traditional Chinese medicine for treating hepatitis
CN101862396A (en) Chinese medicament for treating rheumatism
CN101670047A (en) Hepatitis B treating soup

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140521

WD01 Invention patent application deemed withdrawn after publication